TY - JOUR
AU - Linger, Matthew
AU - Martin, Jennifer
TI - Pharmacovigilance and expedited drug approvals
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2018
VL - 41
IS - 2
SP - 50
EP - 53
DO - 10.18773/austprescr.2018.010
LA - eng
UR - https://australianprescriber.tg.org.au/articles/pharmacovigilance-and-expedited-drug-approvals.html
KW - adverse effects
KW - drug regulation
KW - postmarket surveillance
KW - Therapeutic Goods Administration
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -